176 related articles for article (PubMed ID: 21706236)
21. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
22. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
Bai Y; Wang J; Gao Z; Dai E
Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
[TBL] [Abstract][Full Text] [Related]
23. Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand.
Chanthammachat P; Promwikorn W; Pruegsanusak K; Roytrakul S; Srisomsap C; Chokchaichamnankit D; Svasti J; Boonyaphiphat P; K S; Thongsuksai P
Arch Oral Biol; 2013 Nov; 58(11):1677-85. PubMed ID: 24112734
[TBL] [Abstract][Full Text] [Related]
24. Proteomics of osteosarcoma.
Bernardini G; Laschi M; Geminiani M; Santucci A
Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
[TBL] [Abstract][Full Text] [Related]
25. Comparative proteomic analysis uncovers potential biomarkers involved in the anticancer effect of Scutellarein in human gastric cancer cells.
Saralamma VVG; Vetrivel P; Lee HJ; Kim SM; Ha SE; Murugesan R; Kim EH; Heo JD; Kim GS
Oncol Rep; 2020 Sep; 44(3):939-958. PubMed ID: 32705238
[TBL] [Abstract][Full Text] [Related]
26. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.
Li Y; Dang TA; Shen J; Perlaky L; Hicks J; Murray J; Meyer W; Chintagumpala M; Lau CC; Man TK
Proteomics; 2006 Jun; 6(11):3426-35. PubMed ID: 16673437
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis identifies interleukin 11 regulated plasma membrane proteins in human endometrial epithelial cells in vitro.
Yap J; Foo CF; Lee MY; Stanton PG; Dimitriadis E
Reprod Biol Endocrinol; 2011 May; 9():73. PubMed ID: 21619711
[TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
[TBL] [Abstract][Full Text] [Related]
29. Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway.
Chaiyawat P; Sungngam P; Teeyakasem P; Sirikaew N; Klangjorhor J; Settakorn J; Diskul-Na-Ayudthaya P; Chokchaichamnankit D; Srisomsap C; Svasti J; Pruksakorn D
Int J Oncol; 2019 May; 54(5):1704-1718. PubMed ID: 30816440
[TBL] [Abstract][Full Text] [Related]
30. [Screening proteins related to retinoic acid resistance by proteomic analysis].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
[TBL] [Abstract][Full Text] [Related]
31. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
Davis JL; Horvai AE
Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
[TBL] [Abstract][Full Text] [Related]
33. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
[TBL] [Abstract][Full Text] [Related]
34. PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway.
Zhang HP; Yu ZL; Wu BB; Sun FR
J Orthop Surg Res; 2020 Apr; 15(1):162. PubMed ID: 32334633
[TBL] [Abstract][Full Text] [Related]
35. Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin.
Roy J; Wycislo KL; Pondenis H; Fan TM; Das A
PLoS One; 2017; 12(9):e0183930. PubMed ID: 28910304
[TBL] [Abstract][Full Text] [Related]
36. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
Wang Y; Kuramitsu Y; Yoshino S; Takashima M; Zhang X; Ueno T; Suzuki N; Oka M; Nakamura K
Oncol Rep; 2011 Jul; 26(1):287-92. PubMed ID: 21519797
[TBL] [Abstract][Full Text] [Related]
37. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
38. [Detection of serum biomakers of osteosarcoma by proteomic profiling].
Shen JN; Jin S; Wang J; Huang G; Yin JQ; Guo QC; Li HM; Liu W; Liu SJ; Li MT
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):519-22. PubMed ID: 19062719
[TBL] [Abstract][Full Text] [Related]
39. S100A6 expression and function in human osteosarcoma.
Luo X; Sharff KA; Chen J; He TC; Luu HH
Clin Orthop Relat Res; 2008 Sep; 466(9):2060-70. PubMed ID: 18612712
[TBL] [Abstract][Full Text] [Related]
40. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma.
Ma H; Seebacher NA; Hornicek FJ; Duan Z
EBioMedicine; 2019 Jan; 39():182-193. PubMed ID: 30579871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
